SPL 4.40% 9.5¢ starpharma holdings limited

Key Opinion Leader Jack Sobel, page-17

  1. 321 Posts.
    lightbulb Created with Sketch. 84
    consultants must laughing to see SPL coming miles away. Tell jackie whatever she wants to hear and charge big fees. Yes of course Jackie you should argue with FDA and TGA.

    june 2021 ASX release :
    ”The Boston Consulting Group (BCG) is providing management consulting services, including market analysis, in connection with Starpharma’s development of its go-to-market strategy for Starpharma’s Viraleze Nasal Spray.”

    well that went so well didn’t it?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.004(4.40%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.2¢ 9.6¢ 9.2¢ $80.46K 855.4K

Buyers (Bids)

No. Vol. Price($)
2 8837 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 8838 6
View Market Depth
Last trade - 15.57pm 26/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.